63J-71998-22430
3 vaccinations
2 coded responses
17 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 906 / CA
- Registered
- 2021-03-05
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-08
Dose 1 — Moderna
-
2021-03-05
Registered in v-safe
-
2021-03-05
Dose 2 — Moderna
- 2021-03-05
- 2021-03-05
-
2021-03-06
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-19
- 2021-03-26
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-06-04
-
2021-09-03
Survey response — 6 months, dose 2MedDRA: Dry throat, Somnolence — Feeling: GoodFree text: Grogginess and throat felt dryMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-11-06
Dose 3 — Moderna
-
2022-05-08
Survey response — 6 months, dose 3MedDRA: Nasopharyngitis, Pre-existing disease — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Cold and allergiesMedDRA releases: 2024-11 · check-in free text available
-
2022-05-08
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-05-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-08 | Moderna | |
| 2 | 2021-03-05 | Moderna | |
| 3 | 2021-11-06 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-05-08 | Unsuccessful |
Free text
Release 9 — 6 months, dose 2
Symptoms: Grogginess and throat felt dry
Release 11 — 6 months, dose 3
Symptoms: Cold and allergies
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dry throat | ✓ | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Somnolence | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release